Search the Journal

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Case Report

Successful Treatment of Long-standing Neuro-Behçet's Disease with Infliximab

HAROON SARWAR, HUGH McGRATH Jr, and LUIS R. ESPINOZA

ABSTRACT.

Behçet's disease is a chronic relapsing form of vasculitis affecting multiple organs. Central nervous system involvement is a common presentation. Tumor necrosis factor-a (TNF-a) is considered to play a major role in the disease pathogenesis. We describe a patient with a long history of neuro-Behçet's disease who showed a remarkable response to infliximab therapy. Given the variable and limited success of other interventions, the use of anti-TNF-a therapy seems to be effective for patients with refractory disease. (J Rheumatol 2005;32:181-3)

Key Indexing Terms:

BEHÇET'S DISEASE
INFLIXIMAB
VASCULITIS
TUMOR NECROSIS FACTOR-a
CYTOKINES


From the Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

H. Sarwar, MD, Clinical Rheumatology Fellow; H. McGrath Jr, MD, Professor of Medicine; L.R. Espinoza, MD, Professor of Medicine and Chief, Section of Rheumatology.

Address reprint requests to Dr. L.R. Espinoza, Section of Rheumatology, LSU Health Sciences Center, 1542 Tulane Ave., Box T4M-4, New Orleans, LA 70112, USA. E-mail: lespin1@lsuhsc.edu

Submitted April 1, 2004; revision accepted August 11, 2004.




Return to January 2005 Table of Contents



© 2005. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.